Table 2

 Demographic and clinical characteristics of oral prednisolone and placebo groups at baseline

VariableOral prednisolone (n = 24)Placebo (n = 25)
Values are mean (SD), n, or n (%).
SPADI, shoulder pain and disability index.
Age (years)53.5 (5.1)55.0 (9.0)
Female20 (83.3%)15 (60.0%)
History of shoulder trauma5 (21.7%)4 (16.0%)
Left shoulder affected12 (52.2%)14 (56.0%)
Previous treatment for shoulder pain
    Steroid injections34
    Hydrodilatation31
    Physiotherapy23
    Manipulation under anaesthesia01
Duration of symptoms (weeks)25.5 (13.3)21.1 (13.8)
Severity (out of 10)7.7 (1.5)7.4 (1.8)
SPADI score (0–100)64.7 (14.1)60.5 (19.3)
Croft score (0–21)12.8 (4.1)11.5 (3.6)
Problem elicitation technique score (0–∞)160.0 (71.5)158.7 (76.7)
Pain score (0–10)
    Overall7.3 (1.4)6.8 (1.8)
    At night7.5 (2.3)6.8 (2.1)
    During activity7.9 (1.4)7.9 (1.4)
DASH (0–100)45.0 (16.0)40.2 (17.5)
HAQ disability (0–3)1.4 (0.9)1.1 (0.6)
Range of motion (degrees)
    Total shoulder flexion82.9 (29.4)93.2 (29.5)
    Total shoulder abduction60.0 (26.0)70.2 (25.3)
    External rotation in neutral27.3 (22.8)30.0 (28.9)
Hand behind back18.0 (2.3)18.5 (1.1)
SF-36
    Physical function57.7 (21.0)60.4 (22.8)
    Role physical25.0 (38.3)27.0 (35.3)
    Bodily pain31.7 (16.1)37.1 (18.6)
    General health65.8 (22.0)68.6 (18.9)
    Vitality42.0 (26.3)46.4 (18.0)
    Social function72.0 (26.1)67.5 (29.1)
    Role emotion51.3 (47.1)62.6 (42.3)
    Mental health63.3 (17.6)64.8 (21.2)